Pradeep Bandaru
Pradeep Bandaru
Email verificata su stanford.edu
Titolo
Citata da
Citata da
Anno
FMRP targets distinct mRNA sequence elements to regulate protein expression
M Ascano, N Mukherjee, P Bandaru, JB Miller, JD Nusbaum, DL Corcoran, ...
Nature 492 (7429), 382-386, 2012
5132012
A human B‐cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers
C Lefebvre, P Rajbhandari, MJ Alvarez, P Bandaru, WK Lim, M Sato, ...
Molecular systems biology 6 (1), 377, 2010
3312010
Identification of mRNAs bound and regulated by human LIN28 proteins and molecular requirements for RNA recognition
M Hafner, KEA Max, P Bandaru, P Morozov, S Gerstberger, M Brown, ...
Rna 19 (5), 613-626, 2013
1422013
Deconstruction of the Ras switching cycle through saturation mutagenesis
P Bandaru, NH Shah, M Bhattacharyya, JP Barton, Y Kondo, JC Cofsky, ...
Elife 6, e27810, 2017
462017
The interdependent activation of Son-of-Sevenless and Ras
P Bandaru, Y Kondo, J Kuriyan
Cold Spring Harbor perspectives in medicine 9 (2), a031534, 2019
142019
Mass conservation and inference of metabolic networks from high-throughput mass spectrometry data
P Bandaru, M Bansal, I Nemenman
Journal of Computational Biology 18 (2), 147-154, 2011
52011
Evaluation of the correlation between antibiotic use and survival in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with immune …
PJ Vellanki, S Marur, P Bandaru, PS Mishra-Kalyani, K By, A Girvin, ...
Journal of Clinical Oncology 38 (15_suppl), 6509-6509, 2020
12020
Impact of radiotherapy on risk of adverse events in patients receiving immunotherapy: A US Food and Drug Administration pooled analysis.
MS Anscher, S Arora, C Weinstock, R Lubitz, A Amatya, M Fiero, S Tang, ...
Journal of Clinical Oncology 38 (15_suppl), 3018-3018, 2020
2020
Impact of timing of antibiotic use on clinical outcomes in patients with urothelial cancer treated with immune checkpoint inhibitors (ICIs).
C Weinstock, P Bandaru, LL Fernandes, E Chang, A Girvin, S Tang, ...
Journal of Clinical Oncology 38 (15_suppl), 5045-5045, 2020
2020
Pain medication use in patients with HR+, HER2-neg advanced breast cancer treated with endocrine therapy and a CDK 4/6 inhibitor: A US FDA pooled analysis.
JJ Gao, B King-Kallimanis, C Hodgdon, J Cheng, M Fiero, P Bandaru, ...
Journal of Clinical Oncology 38 (15_suppl), e24145-e24145, 2020
2020
Patient-reported pain and pain medication impact in patients with HR+ Her2-neg advanced breast cancer: A US FDA pooled analysis.
B King-Kallimanis, JJ Gao, C Hodgdon, P Bandaru, A Girvin, C Osgood, ...
Journal of Clinical Oncology 38 (15_suppl), e13027-e13027, 2020
2020
Deconstruction of the Ras switching cycle through saturation mutagenesis reveals hot-spots of allosteric activation
P Bandaru, J Kuriyan, R Ranganathan
PROTEIN SCIENCE 26, 79-79, 2017
2017
Evolutionary constraints on the sequence of Ras
P Bandaru
UC Berkeley, 2017
2017
Identification of mRNAs bound and regulated by human LIN28
M Hafner, KEA Max, P Bandaru
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–14